Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H9ClO2 |
Molecular Weight | 256.684 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=C(C=C1)C2C(=O)C3=C(C=CC=C3)C2=O
InChI
InChIKey=NJDUWAXIURWWLN-UHFFFAOYSA-N
InChI=1S/C15H9ClO2/c16-10-7-5-9(6-8-10)13-14(17)11-3-1-2-4-12(11)15(13)18/h1-8,13H
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0019432 Sources: https://www.ncbi.nlm.nih.gov/pubmed/4067989 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21313725
32 patients were treated in hospital and administered oral tablets of clorindione; 12 mg on the first day, 8 mg on the second day, and 4 mg on the third day. Because of the delayed action of clorindione, Heparin 10,000 iu was given by intramuscular injection on admission and then 5,000 iu every 6 hours for 3 days at 24-hour intervals. Clorindione effectively reduced the prothrombin levels in the patient population back to the desired therapeutic range by the fourth day.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
B01AA09
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
||
|
WHO-VATC |
QB01AA09
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
||
|
NCI_THESAURUS |
C263
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL278519
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
214-553-2
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
541C7WS64R
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
C004665
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
1534
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
1146-99-2
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
3111
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
DTXSID0046228
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
SUB06760MIG
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
C81463
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
m1085
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | Merck Index | ||
|
70846
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
100000084027
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
CLORINDIONE
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
758878
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
DB13275
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
402527
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY |
ACTIVE MOIETY